KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy
暂无分享，去创建一个
M. Berger | M. Weiser | N. Camacho | Raphael A. Pelossof | Ching-Tung Chen | D. Kuk | J. Garcia-Aguilar | J. J. Smith | S. Patil | E. Bergsland | M. Keskin | O. Chow | K. Avila | Zhenbin Chen | J. Smith | J. García-Aguilar | Niedzica Camacho | PhD J. Joshua Smith MD | Deborah Kuk ScM | C. Ms | K. Ms | PhD Julio Garcia-Aguilar MD